ARENTFOX SCHIFF LLP for CHILDREN'S HEALTHCARE OF ATLANTA
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including hospital outpatient department regulations Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities Organ transplant policy generally, including liver transplant distribution methodology Reauthorization of Child Abuse Prevention And Treatment Act (CAPTA) programs H.R. 2076 and S. 1009 (Early Detection to Stop Infant Abuse and Prevent Fatalities Act), all provisions S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA EBINER | — |
| SONJA NESBIT | — |
| DAN RENBERG | — |
Budget/Appropriations BUD
Autism research programs and autism intervention programs generally Department of Education special education programs regarding autism Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 1058 and S. 427 (Autism CARES Act of 2019), all provisions H.R. 2740 (Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020), Division A, Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA EBINER | — |
| SONJA NESBIT | — |
| DAN RENBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.